Immune suppressive effect of cinnamaldehyde due to inhibition of proliferation and induction of apoptosis in immune cells: Implications in cancer

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Roth Walter, Franziska ^a   Moskovskich, Anna ^a   Gomez Casado, Cristina ^b   Diaz Perales, Araceli ^b   Oida, Kumiko ^a,c   Singer, Josef ^d   Kinaciyan, Tamar ^e   Fuchs, Heidemarie C ^f   Jensen Jarolim, Erika ^a,d  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

^c TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e Universitatsklinik fur Dermatologie   (Austria)

^f UNIVERSITY OF APPLIED SCIENCES TECHNIKUM WIEN   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CINNAMALDEHYDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; ACROLEIN; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER THERAPY; CELL IMMORTALIZATION; CELL LINE; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CONCENTRATION RESPONSE; CYTOKINE RELEASE; DRUG ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE SUPPRESSIVE EFFECT; IMMUNOCOMPETENT CELL; JURKAT CELL LINE; MONOCYTE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIMARY CELL; RAJI CELL LINE; RAW264.7 CELL; THP1 CELL LINE; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; CELL SURVIVAL; DRUG EFFECTS; ENZYME ACTIVATION; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; MONONUCLEAR CELL; NEOPLASM;

ACROLEIN; ANIMALS; APOPTOSIS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINES; ENZYME ACTIVATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MICE; MONOCYTES; NEOPLASMS; NF-KAPPA B; NITRIC OXIDE; TRANSCRIPTION FACTOR AP-1;

EID: 84907494021     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108402     Document Type: Article

References (64)

1. Yeh HF, Luo CY, Lin C.Y., Cheng SS, Hsu YR, et al. (2013) Methods for Thermal Stability Enhancement of Leaf Essential Oils and Their Main Constituents from Indigenous Cinnamon (Cinnamomum osmophloeum). J Agric Food Chem 61: 6293-6298.
2. Dhuley JN (1999) Anti-oxidant effects of cinnamon (Cinnamomum verum) bark and greater cardamom (Amomum subulatum) seeds in rats fed high fat diet. Indian J Exp Biol 37: 238-242.
3. Roussel AM, Hininger I, Benaraba R., Ziegenfuss TN, Anderson RA (2009) Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese. J Am Coll Nutr 28: 16-21.
4. Ali SM, Khan AA, Ahmed I, Musaddiq M., Ahmed KS, et al. (2005) Antimicrobial activities of Eugenol and Cinnamaldehyde against the human gastric pathogen Helicobacter pylori. Annals of Clinical Microbiology and Antimicrobials 4.
5. Moleyar V, Narasimham P (1992) Antibacterial activity of essential oil components. International Journal of Food Microbiology 16: 337-342.
6. Koh WS, Yoon SY, Kwon B.M., Jeong TC, Nam KS, et al. (1998) Cinnamaldehyde inhibits lymphocyte proliferation and modulates T-cell differentiation. International Journal of Immunopharmacology 20: 643-660.
7. Reddy AM, Seo JH, Ryu S.Y., Kim YS, Min KR, et al. (2004) Cinnamaldehyde and 2-methoxycinnamaldehyde as NF-kB inhibitors from Cinnamomum cassia. Planta Medica 70: 823-827.
8. Khan A, Safdar M, Khan MMA, Khattak KN, Anderson RA (2003) Cinnamon Improves Glucose and Lipids of People with Type 2 Diabetes. Diabetes Care 26: 3215-3218.
9. De Silva HV, Shankel DM (1987) Effects of the antimutagen cinnamaldehyde on reversion and survival of selected Salmonella tester strains. Mutation Research 187: 11-19.
10. Imai T, Yasuhara K, Tamura T., Takizawa T, Ueda M, et al. (2002) Inhibitory effects of cinnamaldehyde on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung carcinogenesis in rasH2 mice. Cancer Letters 175: 9-16.
11. Moon KH, Pack MY (1983) Cytotoxicity of cinnamic aldehyde on leukemia L1210 cells. Drug and Chemical Toxicology 6: 521-535.
12. Kwon BM, Lee SH, Choi S.U., Park SH, Lee CO, et al. (1998) Synthesis and in vitro cytotoxicity of cinnamaldehydes to human solid tumor cells. Archives of Pharmacal Research 21: 147-152.
13. Jeong HW, Han DC, Son K.H., Han MY, Lim JS, et al. (2003) Antitumor effect of the cinnamaldehyde derivative CB403 through the arrest of cell cycle progression in the G2/M phase. Biochemical Pharmacology 65: 1343-1350.
14. Koppikar SJ, Choudhari AS, Suryavanshi S.A., Kumari S., Chattopadhyay S, et al. (2010) Aqueous Cinnamon Extract (ACE-c) from the bark of Cinnamomum cassia causes apoptosis in human cervical cancer cell line (SiHa) through loss of mitochondrial membrane potential. BMC Cancer 10.
15. Chung WL, Seung HL, Jae W.L., Jung OB, So YL, et al. (2007) 2-Hydroxycinnamaldehyde inhibits SW620 colon cancer cell growth through AP-1 inactivation. Journal of Pharmacological Sciences 104: 19-28.
16. Wu SJ, Ng LT, Lin CC (2005) Cinnamaldehyde-induced apoptosis in human PLC/PRF/5 cells through activation of the proapoptotic Bcl-2 family proteins and MAPK pathway. Life Sciences 77: 938-951.
17. Wu SJ, Ng LT (2007) MAPK inhibitors and pifithrin-alpha block cinnamalde-hyde-induced apoptosis in human PLC/PRF/5 cells. Food and Chemical Toxicology 45: 2446-2453.
18. Cabello CM, Bair WB, Lamore S.D., Ley S., Bause AS, et al. (2009) The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth. Free Radic Biol Med 46: 220-231.
19. Condeelis J, Pollard JW (2006) Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis. Cell 124: 263-266.
20. Mantovani A, Allavena P, Sica A., Balkwill F (2008) Cancer-related inflammation. Nature 454: 436-444.
21. Hanada T, Kobayashi T, Chinen T., Saeki K, Takaki H, et al. (2006) IFNc-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice. Journal of Experimental Medicine 203: 1391-1397.
22. DeNardo DG, Barreto JB, Andreu P, Vasquez L., Tawfik D, et al. (2009) CD4 + T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages. Cancer Cell 16: 91-102.
23. Wang L, Yi T, Kortylewski M., Pardoll DM, Zeng D, et al. (2009) IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. Journal of Experimental Medicine 206: 1457-1464.
24. Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21: 137-148.
25. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V (2012) Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12: 253-268.
26. del Campo AB, Carretero J, Aptsiauri N., Garrido F (2012) Targeting HLA class I expression to increase tumor immunogenicity. Tissue Antigens 79: 147-154.
27. Pages F, Kroemer G (2011) Prognostic impact of anticancer immune responses: an introduction. Semin Immunopathol 33: 317-319.
28. Dietl J, Engel JB, Wischhusen J (2007) The role of regulatory T cells in ovarian cancer. Int J Gynecol Cancer 17: 764-770.
29. Heimdal JH, Aarstad HJ, Klementsen B, Olofsson J (1999) Peripheral blood mononuclear cell (PBMC) responsiveness in patients with head and neck cancer in relation to tumour stage and prognosis. Acta Otolaryngol 119: 281-284.
30. Parkman R, Cohen G, Carter S.L., Weinberg KI, Masinsin B, et al. (2006) Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation. Biol Blood Marrow Transplant 12: 919-927.
31. Karagiannis P, Singer J, Hunt J., Gan SK, Rudman SM, et al. (2009) Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells. Cancer Immunol Immunother 58: 915-930.
32. Gupta S, Carballido E, Fishman M (2011) Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatments. Onco Targets Ther 4: 79-96.
33. Kwek SS, Cha E, Fong L (2012) Unmasking the immune recognition of prostate cancer with CTLA4 blockade. Nat Rev Cancer 12: 289-297.
34. Roth-Walter F, Pacios LF, Gomez-Casado C, Hofstetter G., Roth GA, et al. (2014) The Major Cow Milk Allergen Bos d 5 Manipulates T-Helper Cells Depending on Its Load with Siderophore-Bound Iron. PLoS One 9: e104803.
35. Roth-Walter F, Gomez-Casado C, Pacios L.F., Mothes-Luksch N, Roth GA, et al. (2014) Bet v 1 from Birch Pollen Is a Lipocalin-like Protein Acting as Allergen Only When Devoid of Iron by Promoting Th2 Lymphocytes. J Biol Chem 289: 17416-17421.
36. Liao BC, Hsieh CW, Liu Y.C., Tzeng TT, Sun YW, et al. (2008) Cinnamaldehyde inhibits the tumor necrosis factor-alpha-induced expression of cell adhesion molecules in endothelial cells by suppressing NF-kappaB activation: effects upon IkappaB and Nrf2. Toxicol Appl Pharmacol 229: 161-171.
37. Kwon HK, Hwang JS, So J.S., Lee CG, Sahoo A, et al. (2010) Cinnamon extract induces tumor cell death through inhibition of NFkappaB and AP1. BMC Cancer 10: 392.
38. Cao H, Graves DJ, Anderson RA (2010) Cinnamon extract regulates glucose transporter and insulin-signaling gene expression in mouse adipocytes. Phytomedicine 17: 1027-1032.
39. Liao JC, Deng JS, Chiu C.S., Hou WC, Huang SS, et al. (2012) Anti-Inflammatory Activities of Cinnamomum cassia Constituents In Vitro and In Vivo. Evid Based Complement Alternat Med 2012: 429320.
40. Youn HS, Lee JK, Choi Y.J., Saitoh SI, Miyake K, et al. (2008) Cinnamaldehyde suppresses toll-like receptor 4 activation mediated through the inhibition of receptor oligomerization. Biochem Pharmacol 75: 494-502.
41. Anand P, Kunnumakkara AB, Sundaram C, Harikumar K.B., Tharakan ST, et al. (2008) Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 25: 2097-2116.
42. Pawelec G, Derhovanessian E, Larbi A (2010) Immunosenescence and cancer. Crit Rev Oncol Hematol 75: 165-172.
43. Motz GT, Coukos G (2013) Deciphering and reversing tumor immune suppression. Immunity 39: 61-73.
44. Krummel MF, Allison JP (1996) CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 183: 2533-2540.
45. Leach DR, Krummel MF, Allison JP (1996) Enhancement of antitumor immunity by CTLA-4 blockade. Science 271: 1734-1736.
46. Hodi FS, O'Day SJ, McDermott DF, Weber R.W., Sosman JA, et al. (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363: 711-723.
47. Robert C, Thomas L, Bondarenko I., O'Day S, Weber J, et al. (2011) Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med 364: 2517-2526.
48. Oida K, Matsuda A, Jung K., Xia Y, Jang H, et al. (2014) Nuclear factor-kB plays a critical role in both intrinsic and acquired resistance against endocrine therapy in human breast cancer cells. Sci Rep 4: 4057.
49. Naugler WE, Karin M (2008) NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 18: 19-26.
50. Yuan J, Dieter MP, Bucher J.R., Jameson CW (1993) Application of microencapsulation for toxicology studies. III. Bioavailability of microencapsu-lated cinnamaldehyde. Fundam Appl Toxicol 20: 83-87.
51. Peters MM, Caldwell J (1994) Studies on trans-cinnamaldehyde. 1. The influence of dose size and sex on its disposition in the rat and mouse. Food Chem Toxicol 32: 869-876.
52. Yuan JH, Dieter MP, Bucher J.R., Jameson CW (1992) Toxicokinetics of cinnamaldehyde in F344 rats. Food Chem Toxicol 30: 997-1004.
53. Zhao H, Xie Y, Yang Q., Cao Y, Tu H, et al. (2014) Pharmacokinetic study of cinnamaldehyde in rats by GC-MS after oral and intravenous administration. J Pharm Biomed Anal 89: 150-157.
54. The Flavor and Fragrance High Production Volume Consortia, Consortium TA (2006) Revised Test Plan for Cinnamyl Derivatives. United States Environmental Protection Agency.
55. Balkwill F (2002) Tumor necrosis factor or tumor promoting factor? Cytokine and Growth Factor Reviews 13: 135-141.
56. Moore KW, De Waal Malefyt R, Coffman RL, O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology. pp. 683-765.
57. Kwon HK, Jeon WK, Hwang J.S., Lee CG, So JS, et al. (2009) Cinnamon extract suppresses tumor progression by modulating angiogenesis and the effector function of CD8 + T cells. Cancer Lett 278: 174-182.
58. Kegley SE, Hill BR, Ome S, Choi AH (2010) PAN Pestidice Database. San Francisco, CA: Pesticide Action Network.
59. Mereto E, Brambilla-Campart G, Ghia M., Martelli A, Brambilla G (1994) Cinnamaldehyde-induced micronuclei in rodent liver. Mutat Res 322: 1-8.
60. Westra WH, McMurray JS, Califano J, Flint P.W., Corio RL (1998) Squamous cell carcinoma of the tongue associated with cinnamon gum use: a case report. Head Neck 20: 430-433.
61. - (2006) High daily intakes of cinnamon: Health risk cannot be ruled out. Germany: Federal Institute for Risk Assessment, BfR, of the Federal Ministry of Food and Agriculture (BMEL).
62. Dornish JM, Pettersen EO, Oftebro R (1989) Modifying effect of cinnamalde-hyde and cinnamaldehyde derivatives on cell inactivation and cellular uptake of cis-diamminedichloroplatinum(II) in human NHIK 3025 cells. Cancer Res 49: 3917-3921.
63. Kumar C, Igbaria A, D'Autreaux B, Planson AG, Junot C, et al. (2011) Glutathione revisited: a vital function in iron metabolism and ancillary role in thiol-redox control. EMBO J 30: 2044-2056.
64. Olsen RV, Andersen HH, Moller H.G., Eskelund PW, Arendt-Nielsen L (2014) Somatosensory and vasomotor manifestations of individual and combined stimulation of TRPM8 and TRPA1 using topical L-menthol and trans-cinnamaldehyde in healthy volunteers. Eur J Pain.